CAS 75799-04-1: (3β,9β,10α,22S,23R,24R)-22,23,24,25-Tetrahydroxy-9-methyl-19-norlanost-5-en-3-yl O-β-D-glucopyranosyl-(1→6)-O-[β-D-xylopyranosyl-(1→4)]-β-D-glucopyranoside

Momordicoside B is a bioactive triterpenoid saponin, which is a compound sourced from the fruit of Momordica charantia, commonly known as bitter melon. This fruit is widely studied for its role in traditional medicine and its diverse pharmacological activities. The mode of action of Momordicoside B involves the modulation of glucose metabolism pathways. It is known to influence the activity of enzymes involved in glucose utilization and insulin sensitization, providing biochemical pathways that mimic insulin activity. In scientific research, Momordicoside B is utilized predominantly for its antidiabetic properties, supporting the regulation of blood sugar levels. Its antioxidative, anti-inflammatory, and hepatoprotective effects have also attracted interest, making it a compound of study for related metabolic disorders. Additionally, its potential therapeutic applications extend to cancer research, where its ability to induce apoptosis in certain cancer cell lines has been observed. This compound continues to be a subject of interest due to its natural origin, multifaceted biological activity, and potential contributions to the development of therapeutic agents targeting complex metabolic conditions.